v3.26.1
Note B - The Company and its Significant Accounting Policies (Details Textual) - USD ($)
shares in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Nov. 30, 2025
Oct. 31, 2025
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest $ (7,804,000) $ (2,055,000)    
Retained Earnings (Accumulated Deficit) (12,249,000) (4,445,000)    
Cash and Cash Equivalent 3,758,000 4,034,000    
Working Capital (Deficit) 3,144,000      
Proceeds from Issuance of Private Placement 14,000,000      
Revenue from Contract with Customer, Excluding Assessed Tax 1,024,000 0    
Accounts Receivable, after Allowance for Credit Loss 330,000 0    
Goodwill 984,000 0    
Unrecognized Tax Benefits $ 0 $ 0    
Weighted Average Number of Shares Outstanding, Diluted, Adjustment 0 0    
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 0 0    
Advertising Expense $ 0 $ 0    
Domestic Tax Jurisdiction [Member]        
Open Tax Year 2020 2021 2022 2023 2024 2025      
State and Local Jurisdiction [Member]        
Open Tax Year 2020 2021 2022 2023 2024 2025      
Physician Support Systems (PSS) [Member]        
Goodwill $ 984,000   $ 4,962,000 $ 4,962,304
Organic Operations [Member]        
Revenue from Contract with Customer, Excluding Assessed Tax $ 0 $ 0